Article Abstract
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: We read with great interest the recent article by Martinet al.1 reporting that the bleeding risk associated with use of selectiveserotonin reuptake inhibitors (SSRIs) during antiviraltherapy for chronic hepatitis C (CHC) is lower than that previouslyreported.2 Several reports had revealed the increasing riskof bleeding, including retinal hemorrhages or gastrointestinalbleeding, by administrating SSRIs to patients receiving interferon-α therapy.3-6Ribavirin was used in combination with interferon in thetreatment of patients with CHC in the study by Martin et al.1‘ ‹
From the Editors
New Series
The JCP Podcast
Insightful, evidence-based conversations on the latest in psychiatric care — from the editors of JCP.
Download Free PDF
This PDF is free for all visitors!
